PoltregWAR:PTG +1.86%46 Gross Margin % is 0.00% as of Mar. 2026. GuruFocus rates WAR:PTG with a GF Score™ of 46/100 and a GF Value™ of zł14.20 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 731 Biotechnology companies, Poltreg ranks worse than 136798.77% on this metric.
Gross Margin % is calculated as gross profit divided by its revenue. Poltreg's Gross Profit for the
three
months ended in Mar. 2026 was zł-1.35 Mil. Poltreg's Revenue for the
three
months ended in Mar. 2026 was zł0.00 Mil. Therefore, Poltreg's Gross Margin % for the quarter that ended in Mar. 2026 was 0.00%.
The historical rank and industry rank for Poltreg's Gross Margin % or its related term are showing as below:
During the past 8 years, the highestGross Margin % of Poltreg was 74.34%. The lowest was -1270.00%. And the median was 16.00%.
WAR:PTG's Gross Margin % is not ranked *
in the Biotechnology industry.
Industry Median: 60.91 * Ranked among companies with meaningful Gross Margin % only.
Poltreg had a gross margin of % for the quarter that ended in Mar. 2026 => No sustainable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Poltreg was 0.00% per year.
Poltreg (WAR:PTG) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Poltreg had a gross margin of % for the quarter that ended in Mar. 2026 => No sustainable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Poltreg Gross Margin % Related Terms
Poltreg Gross Margin % Historical Data
* Premium members only.
The historical data trend for Poltreg's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WAR:PTG vs VRTX, REGN, ALNY: Gross Margin % Comparison
For the Biotechnology subindustry, Poltreg's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Poltreg Gross Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Poltreg's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Poltreg's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Poltreg (WAR:PTG) has a Gross Margin % of 0.00% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Poltreg and its competitors. According to the industry distribution chart, Poltreg ranks #999999 out of 731 companies in the Biotechnology industry.
Is Poltreg's Gross Margin % too high?
Poltreg's current Gross Margin % is 0.00%. Based on the distribution chart, Poltreg ranks #999999 out of 731 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Poltreg has a GF Score™ of 46/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Poltreg's Gross Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Poltreg ranks #999999 out of 731 companies for Gross Margin %. This places Poltreg in the lower half of its industry. The industry median Gross Margin % is 60.91. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Biotechnology company?
The median Gross Margin % among Biotechnology companies is 60.91, based on 731 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Poltreg and its competitors. For the Biotechnology industry, the median Gross Margin % is 60.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Poltreg's current Gross Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Poltreg stock overvalued right now?
Based on GuruFocus' analysis, Poltreg (WAR:PTG) is currently considered Significantly Overvalued. The stock's GF Value™ is zł14.20, compared to a current price of zł19.15 — trading 34.9% above its estimated fair value. The current Gross Margin % is 0.00%. Poltreg's overall GF Score™ is 46/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Poltreg (WAR:PTG), the current Gross Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Poltreg (WAR:PTG) Overvalued in 2026?
Based on GuruFocus' analysis, Poltreg stock appears to be overvalued.
The current stock price of zł19.15 is trading 34.9% above its estimated GF Value™ of zł14.20.
GuruFocus considers Poltreg to be Significantly Overvalued.
Key valuation signals for WAR:PTG:
Gross Margin %: 0.00%
GF Value™: zł14.20 vs. price of zł19.15 (34.9% above fair value)
No single metric tells the full story. See the WAR:PTG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Poltreg SA is a biotechnology company at the clinical stage developing an innovative generation of medicines using T-regulatory cells (TREGS) in the treatment of autoimmune diseases.
46GF Score
Get the complete analysis for WAR:PTG
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:PTG has been successfully added to your 
